https://imedic.health/en/health/news/glp1-use-young-children-obesity-rising-safety iMedic en 2026-09-26 GLP-1 Use in Young Children With Obesity Is Rising: What Families Should Know https://imedic.health/en/health/news/generic-baloxavir-pandemic-flu-treatment-access iMedic en 2026-09-26 Generic Baloxavir Deals Could Expand Access to Pandemic Flu Treatment https://imedic.health/en/health/news/antidepressants-qtc-heart-risk-major-depression iMedic en 2026-09-26 Antidepressants, QTc Changes and Early Heart Risk: What Patients Should Know https://imedic.health/en/health/news/estrogen-only-hormone-therapy-dementia-risk-menopause iMedic en 2026-09-26 Estrogen-Only Hormone Therapy and Dementia Risk: What New Findings Mean https://imedic.health/en/health/news/nmpa-30-working-day-ind-pathway-clinical-trial-design iMedic en 2026-09-26 NMPA 30-Working-Day IND Pathway: How Drug Developers Can Prepare https://imedic.health/en/health/news/global-clinical-trial-design-china-accelerated-ind-review iMedic en 2026-09-26 Global Clinical Trial Design for China’s Accelerated IND Review https://imedic.health/en/health/news/exercise-after-chemotherapy-colon-cancer-survival iMedic en 2026-09-26 Colon Cancer Survival: Can Exercise After Chemotherapy Help? https://imedic.health/en/health/news/neonatal-parenteral-nutrition-fda-starter-supply-access iMedic en 2026-09-27 Neonatal Parenteral Nutrition: What Does FDA Action Mean? https://imedic.health/en/health/news/waist-size-heart-disease-risk-beyond-bmi iMedic en 2026-09-27 Waist Size and Heart Disease: What Can BMI Miss? https://imedic.health/en/health/news/postpartum-intrusive-thoughts-infant-harm-research iMedic en 2026-09-27 Postpartum Intrusive Thoughts: Do They Signal Danger? https://imedic.health/en/health/news/type-2-diabetes-heart-kidney-complications-ten-year-risk iMedic en 2026-09-27 Type 2 Diabetes: What Does a 55% Complication Risk Mean? https://imedic.health/en/health/news/nasal-pain-relief-children-emergency-care-injections iMedic en 2026-09-27 Nasal Pain Relief for Children: Can It Replace Injections? https://imedic.health/en/health/news/ctx310-cholesterol-gene-editing-one-year-durability-results iMedic en 2026-09-27 CTX310 Cholesterol Gene Editing: What Do One-Year Data Show? https://imedic.health/en/health/news/evinacumab-angptl3-inherited-high-cholesterol-treatment iMedic en 2026-09-27 Evinacumab: Who Benefits From ANGPTL3 Cholesterol Treatment? https://imedic.health/en/health/news/libre-duo-fda-authorization-continuous-glucose-ketone-monitoring iMedic en 2026-09-27 Libre Duo: How Can Glucose-Ketone Monitoring Help? https://imedic.health/en/health/news/fda-approved-drugs-china-manufacturing-quality-treatment-access iMedic en 2026-09-28 FDA-Approved Drugs: What Does China’s Growing Role Mean? https://imedic.health/en/health/news/alzheimers-agitation-auvelity-rexulti-caregiver-treatment iMedic en 2026-09-28 Alzheimer’s Agitation: What Can New Drug Options Offer? https://imedic.health/en/health/news/exam-stress-blood-sugar-medical-students iMedic en 2026-09-28 Exam Stress and Blood Sugar: What a Student Study Found https://imedic.health/en/health/news/alzheimers-drugs-family-treatment-benefits-risks iMedic en 2026-09-28 Alzheimer's Drugs: How Should Families Weigh Treatment? https://imedic.health/en/health/news/fda-master-protocols-shared-clinical-trials-drug-development iMedic en 2026-09-28 FDA Master Protocols: Can Shared Trials Speed New Drugs? https://imedic.health/en/health/news/pelacarsen-heart-trial-setback-lipoprotein-a-treatment iMedic en 2026-09-28 Pelacarsen Heart Trial: What Does the Lp(a) Setback Mean? https://imedic.health/en/health/news/cholesterol-drug-trials-biomarkers-heart-protection-evidence iMedic en 2026-09-28 Cholesterol Drug Trials: What Proves Heart Protection?